Inherited endocrine tumors have been increasingly recognized in clinical practice, although
some difficulties still exist in differentiating these conditions from their sporadic endocrine …

Neuroendocrine neoplasms (NENs) arise from cells of the neuroendocrine system located in
many sites amongst which most common are the gastrointestinal (GI) system and the lung …

In the last two decades, the increasing availability of technologies for molecular analyses
has allowed an insight in the genomic alterations of neuroendocrine neoplasms (NEN) of …

Objective Our aim was to assess the prevalence of endocrine paraneoplastic syndromes
(EPNS) in neuroendocrine neoplasms (NENs) and estimate its impact on patient outcomes …

Endocrine tumor syndromes, eg, multiple endocrine neoplasia types 1 and 2, were among
the first recognized hereditary predisposition syndromes to tumor development. Over time …

Molecular profiling of GEP-NETs demonstrates that pancreatic endocrine tumors and
gastrointestinal neuroendocrine tumors (carcinoids) display different genetic changes and …

All neuroendocrine neoplasms (NENs) are characterized by the expression of
synaptophysin and chromogranin A (or B). Yet, they are not a homogeneous group of …

Small intestine neuroendocrine tumors (SI-NETs) are the most common malignancy of the
small bowel. Several clinical trials target PI3K/Akt/mTOR signaling; however, it is unknown …

In the lung, neuroendocrine tumors (NETs), namely typical and atypical carcinoids, and
neuroendocrine carcinomas (NECs), grouping small cell carcinoma (SCLC) and large cell …

Pancreatic neuroendocrine tumors (pNETs) are the second most prevalent neoplasms of the
pancreas with variable prognosis and clinical course. Our knowledge of the genetic …